Scope of Review & Responsibility

The Institutional Biosafety Committee (IBC) was established to provide local review and oversight of any work that is regulated by the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. The University of Illinois at Chicago (UIC) is required to comply with this regulation as an NIH-funded institution. The NIH Guidelines include the use, modification, and/or transfer of recombinant or synthetic nucleic acid materials, including genetically modified organisms.

In addition to the NIH Guidelines, our IBC is charged with oversight of all research and teaching involving infectious agents, biological toxins, and select agents. This oversight ensures compliance with  the Centers for Disease Control and uses the Biosafety in Microbiological and Biomedical Laboratories as a guide. The IBC ensures proper concern for the safety of personnel, the environment, and the surrounding communities.

The Biological Safety group within the Environmental Health and Safety office (EHSO) partners with the IBC to provide technical expertise and training on the projects overseen by the IBC. It is important to regularly review all policies and guidance provided by the Biological Safety group to ensure knowledge of updates.

To this end, the IBC reviews, approves, and oversees work performed with the following biological materials in research, teaching, or training:

The IBC is managed by the OACIB, which accepts all protocol and modification submissions, coordinates protocol review, notifies the investigator of the outcome of review, and works with investigators during the writing/revision process.

Please submit protocols and modifications directly to oacib@uic.edu and contact us if you have any questions.